Ajinomoto Co., Inc. announced that it has executed a merger agreement to acquire all of the capital stock of Althea Technologies, Inc., a leading biop

Abbott has completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company.